

Is Paxlovid still in shortage in 2026? Get the latest update on availability, pricing, and what to do if you can't find it at your pharmacy.
If you've recently tested positive for COVID-19 and your pharmacy told you Paxlovid is unavailable, you're probably wondering: is there still a Paxlovid shortage? The answer is complicated — and depends on where you live, when you're looking, and what's happening with COVID-19 in your area.
In this article, we'll give you a clear, up-to-date picture of Paxlovid availability in 2026, what's driving any shortages, and what you can do to get the treatment you need.
As of early 2026, Paxlovid is not in a nationwide shortage in the way it was during early 2022 when manufacturing was still ramping up. Pfizer has significantly increased production capacity, and the medication is widely distributed through the commercial pharmacy supply chain.
However, localized shortages continue to occur, especially during:
The pattern is clear: when COVID-19 cases spike in an area, local pharmacies can run through their Paxlovid supply within days, creating temporary stock-outs even though overall national supply is adequate.
Several factors continue to make Paxlovid harder to find than a typical prescription:
Unlike medications for chronic conditions (where demand is steady and predictable), Paxlovid demand follows COVID-19 case patterns — quiet for weeks, then surging suddenly. Pharmacies can't easily predict when they'll need it, and most don't stockpile it due to cost and shelf-life concerns.
A single course of Paxlovid costs approximately $1,200 to $1,500 at retail price. This high cost means pharmacies face significant financial risk if they stock doses that expire unused. As a result, many pharmacies — especially smaller ones — keep limited inventory.
Since the end of the government distribution program in late 2023, Paxlovid has moved through standard commercial channels. This means pharmacies order it from wholesalers alongside thousands of other medications, and it competes for shelf space and ordering priority like any other drug. The guaranteed government supply pipeline no longer exists.
Many insurance plans require prior authorization for Paxlovid, which can delay access by hours or even days. Some plans also have high copays, which may discourage patients from filling the prescription even when it's available.
Here's a breakdown of what you might pay for Paxlovid:
For more details on reducing your costs, read our full guide on how to save money on Paxlovid in 2026.
The COVID-19 treatment landscape continues to evolve. While Paxlovid remains the most widely prescribed oral antiviral for high-risk patients, other options exist:
Learn more about treatment options in our guide to Paxlovid alternatives.
If you need Paxlovid and your pharmacy is out, here's what to do:
For a complete walkthrough, see our article on how to find Paxlovid in stock near you.
Paxlovid is not in a broad national shortage in 2026, but localized stock-outs remain a real challenge — especially during COVID-19 surges. The combination of unpredictable demand, high per-unit cost, and insurance hurdles means finding Paxlovid can still feel like a scavenger hunt at the worst possible time.
Your best strategy: act fast, use Medfinder to check availability, and don't hesitate to call multiple pharmacies. The five-day treatment window waits for no one.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.